Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

23 Daily use of illicit morphine in the previous six months increased to 30% of the sample, a significant increase from the 8% who reported daily use in 2010 (Table 15). Daily use of licit morphine remained at 15% of the sample. Table 15: Frequency of illicit morphine use in previous six months, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Any Illicit Licit Any Illicit Licit Any Illicit Licit Any Illicit Licit Any Illicit Licit No recent use 22 31 69 14 19 81 31 40 80 9 15 79 19 28 72 Weekly or less 12 21 3 13 19 0 2 5 2 14 20 1 14 20 5 More than weekly 21 28 8 21 23 3 28 37 4 29 37 5 19 22 7 Daily 45 20 21 52 38 17 38 18 14 48 8 15 47 30 15 Source: IDRS participant interviews 4.6.3 Oxycodone Thirty-two percent of respondents reported use of some form of oxycodone in the six months preceding the interview, an almost identical proportion to the 33% who reported recent oxycodone use in 2010 (Table 16). Recent use of illicit oxycodone increased from 22% of the sample in 2010 to 26% in 2011. The proportion of those who injected illicit oxycodone (23%) exceeded those who injected licit oxycodone (6%). Median days used for licit oxycodone again exceeded that of illicit oxycodone (72 days compared to 3 days) but this was lower than the 126 days median use of licit oxycodone reported in 2010. There was a concurrent reduction in median days licit oxycodone was recently injected, from 180 days in 2010 to 72 days in 2011. Table 16: Selected trends in participants recent oxycodone use, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Licit Illicit Any Licit Illicit Any Licit Illicit Any Licit Illicit Any Licit Illicit Any Used last 6 months 2 11 12 3 28 31 9 35 41 12 22 33 8 26 32 Injected last 6 months 0 9 9 3 26 29 3 31 32 8 20 27 6 23 27 Days used last 6 months (median) 24 4 4 68 8 13 18 3 8 126 5 7 72 3 72 Days injected last 6 months (median) 0 4 4 65 8 14 4 3 6 180 5 7 72 3 5 Source: IDRS participant interviews In 2011, 26% of respondents reported recent use of illicit oxycodone, far more than the 8% who reported recent use of licit oxycodone (Table 17). Oxycontin was again the main brand used.


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.